Wesper announced on Jan. 25, 2022, that it received FDA clearance for its Wesper Lab system, which assists trained personnel in the diagnosis of obstructive sleep apnea (OSA) with data from a wireless patch component.
About Wesper Lab
Wesper Lab is a digital recording device designed to be used under the direction of physician or trained technician but may be applied by a patient from the home. The system includes an abdominal patch, a thoracic patch and a mobile app. The single-use patches are flexible, thin and wireless. The app relays sleep data for interpretation by a health care professional, assisting in the identification of OSA.
The device records multiple physiological parameters, including sleep position and respiratory effort. Wesper Lab is coupled with an authorized FDA-cleared pulse oximeter to measure pulse rate and oxygen saturation.
According to the company, Wesper Lab is intended to be used for adult sleep studies at home or in a clinical environment.
About obstructive sleep apnea
OSA is a serious sleep disorder where the airway becomes repeatedly blocked during sleep, causing pauses in breathing. This condition, often marked by loud snoring and choking noises, can lead to oxygen deprivation, disrupting sleep and contributing to various health issues such as high blood pressure, heart disease, stroke and diabetes.
Read more industry news from the AASM.
